Krystal Biotech Cash from Investing (TTM) Analysis

Krystal Biotech Inc (KRYS)

158.74 +1.06 (+0.67%) USD | NASDAQ | May 09, 16:00

158.74 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	53.10M
December 31, 2023	82.64M
September 30, 2023	87.59M
June 30, 2023	-32.34M
March 31, 2023	-54.61M
December 31, 2022	-114.08M
September 30, 2022	-235.42M
June 30, 2022	-257.84M
March 31, 2022	-281.93M
December 31, 2021	-226.77M
September 30, 2021	-106.45M
June 30, 2021	-71.98M
March 31, 2021	-10.62M

Date	Value
December 31, 2020	-11.18M
September 30, 2020	-5.555M
June 30, 2020	-3.54M
March 31, 2020	-3.814M
December 31, 2019	-4.991M
September 30, 2019	-8.167M
June 30, 2019	-10.24M
March 31, 2019	-12.80M
December 31, 2018	-10.32M
September 30, 2018	-6.715M
June 30, 2018	-3.972M
March 31, 2018	-0.203M
December 31, 2017	-0.21M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-281.93M

Minimum

Mar 2022

87.59M

Maximum

Sep 2023

-60.81M

Average

-10.90M

Median

Cash from Investing (TTM) Benchmarks